Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European study on glycogen storage disease type 1

European Journal of Pediatrics, Supplement

Volumn 161, Issue 1, 2002, Pages S83-S87

  Visser, Gepke ^a,h   Peter Rake, Jan ^a   Labrune, Philippe ^b   Leonard, James V ^c   Moses, Shimon ^d   Ullrich, Kurt ^e   Wendel, Udo ^f   Groenier, Klaas H ^g   Smit, G Peter A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Granulocyte colony stimulating factor; Gylcogen storage disease type 1b; Neutropenia; Treatment

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BONE PAIN; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; EUROPE; FEMALE; FEVER; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOGLOBIN DETERMINATION; HUMAN; HYPERSPLENISM; INFECTION; INFLAMMATORY DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; SCHOOL CHILD; SPLENOMEGALY; THROMBOCYTE COUNT;

CHILD; FEMALE; GLYCOGEN STORAGE DISEASE TYPE I; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; NEUTROPENIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036390010     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02680001     Document Type: Article

References (28)

1. Altman DG (1991) Quantifying variability. In: Altman DG (ed) Practical statistics for medical research, 1st edn. Chapman and Hall, London, pp 33
2. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi PG (2000) Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 247: 63-70
3. Arion WJ, Canfield WK, Callaway ES, Burger HJ, Hemmerle H, Schubert G, Herling AW, Oekonomopulos R (1998) Direct evidence for the involvement of two glucose 6-phosphate-binding sites in the glucose-6-phosphatase activity of intact liver microsomes - characterization of T1, the microsomal glucose 6-phosphate transport protein by a direct binding assay. J Biol Chem 273: 6223-6227
4. Burchell A (1990) Molecular pathology of glucose-6-phosphatase. FASEB J 4: 2978-2988
5. Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J (2001) Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 97: 376-382
6. Carapeti M, Soede-Bobok A, Hochhaus A, Sill H, Touw IP, Goldman JM, Cross NCP (1997) Rarity of dominant-negative mutations of the GCSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia. Leukemia 11: 1005-1008
7. Cowan FJ, Warner JT, Dunstan FDJ, Evans WD, Gregory JW, Jenkins HR (1997) Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 76: 325-329
8. Dong F, Dale DC, Bonilla MA, Freedman M, Fasth A, Neijens HJ, Palmblad J, Briars GL, Carlsson G, Veerman AJP, Welte K, Löwenberg B, Touw IP (1997) Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 11: 120-125
9. Fata F, Myers P, Addeo J, Grinberg M, Nawabi I, Cappell MS (1997) Cyclic neutropenia in Crohn's ileocolitis: efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol 24: 253-256
10. Fernandes J, Saudubray J-M, van den Berghe G (2000) Glycogen storage diseases. In: Fernandes J, Chen Y-T (eds) Inborn metabolic diseases, 3rd edn. Springer, Berlin Heidelberg New York, pp 85-93
11. Fewtrell MS, Kinsey SE, Williams DM, Bishop NJ (1997) Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor. Br J Haematol 97: 734-736
12. Frampton JE, Lee CR, Faulds D (1994) Filgrastim: a review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48: 731-760
13. Frampton JE, Yarker YE, Goa KL (1995) Lenograstim: a review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings. Drugs 49: 767-793
14. Hommes DW, Meenan J, Dijkhuizen S, Ten Kate FJ, Tytgat GN, Van Deventer SJ (1996) Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis. Clin Exp Immunol 106: 529-533
15. Höglund M, Ha.kansson L, Venge P (1997) Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers. Eur J Haematol 58: 195-202
16. Ishiguro A, Nakahata T, Amano Y, Yasaui K, Koike K, Komiyama A (1993) Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type 1b. J Pediatr 152: 18-20
17. Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ (1995) Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 154: 483-487
18. Lin B, Hiraiwa H, Pan CJ, Nordlie RC, Chou JY (1999) Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene. Hum Genet 105: 515-517
19. Marcolongo R, Zambello R, Trentin L, Cassatella M, Gasparotto G, Agostini C (1995) Childhood onset cyclic neutropenia: G-CSF therapy restores neutrophil count but does not influence superoxide anion and cytokine release by neutrophils. Br J Haematol 89: 277-281
20. Narisawa K, Otomo H, Igarashi Y, Arai N, Otake M, Tada K, Kuzuya T (1983) Glycogen storage disease type 1b: microsomal glucose-6-phosphatase system in two patients with different clinical findings. Pediatrics 17: 545-549
21. Schroten H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes M, Wahn V, Welte K (1991) Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type 1b. J Pediatr 119: 748-754
22. Shanahan F, Bernstein CN (1993) Odd forms of inflammatory bowel disease: what can they tell us? Gastroenterology 104: 327-329
23. Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type 1a. Eur J Pediatr 152[suppl 1]: S52-S55
24. Spiekermann K, Roesler J (1995) G-CSF and neutrophil chemotaxis. Br J Haematol 90: 232-233
25. Turilli I, Bowers D, Aronson I, Woods L, Jacobs P (1995) G-CSF and neutrophil chemotaxis. Br.J.Haematol. 90: 232-233
26. Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L (2000) Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 46: 176-181
27. Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GPA (2000) Neutropenia, neutrophil dysfunction and inflammatory bowel disease in glycogen storage disease type 1b. J Pediatr 137: 187-191
28. Wallace JL, McKnight W, Asfaha S, Liu DY (1998) Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol 274: G802-G808